Determination of BCR/ABL translocation in radiation-associated acute myeloid leukemia patients by fluorescence in situ hybridization

Cytology and Genetics

Volumn 39, Issue 6, 2005, Pages 55-59

  Klimenko, S V ^a   Misharina, Zh A ^a   Abramenko, I V ^a   Bilous, N I ^a   Bebeshko, V G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETICS; HUMAN; IONIZING RADIATION; MALE; RADIATION ACCIDENT; UKRAINE;

ACCIDENTS, RADIATION; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; RADIATION, IONIZING; TRANSLOCATION, GENETIC; UKRAINE;

EID: 33845796968     PISSN: 05643783     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Vardiman J.W., Harris N.L., Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms // Blood. - 2002. - 100. - P. 2292-2302.
2. Barnes D.J., Melo J.V. Cytogenetic and molecular genetic aspects of chronic myeloid leukemia // Acta Haematol. - 2002. - 108. - P. 180-202.
3. Kurzrock R., Bueso-Ramos C.E., Kantarjian H.M., et al. BCR rearrangement-negative chronic myelogenous leukemia revisited // J. Clin. Oncol. - 2001. - 19. - P. 2915-2926.
4. Pui C.H., Relling M.V., Downing J.R. Acute lymphoblastic leukemia // N. Engl. J. Med. - 2004. - 350. - P. 1535-1548.
5. Paietta E., Racevskis J., Bennett J.M., et al. Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience // Leukemia. - 1998. - 12. - P. 1881-1885.
6. Keung Y.K., Beaty M., Powell B.L., et al. Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature // Leuk. Res. - 2004. - 28. - P. 579-586.
7. Deininger M.W.N., Bose S., Gora-Tybor J. et al. Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation // Cancer Res. - 1998. - 58. - P. 421-425.
8. Likhtarev I.A., Chumack V.V., Repin V.S. Retrospective reconstruction of individual and collective external gamma doses of population evacuated after the Chernobyl accident // Health Phys. - 1994. - 66. - P. 643-652.
9. Hassan R., Otazu I., Ornellas M.H. et al. A child with Philadelphia positive (ph+)-acute leukemia with myeloid morphology: one case of stem cell origin // Leuk. Lymphoma. - 2004. - 45. - P. 1925-1929.
10. Advani A.S., Pendergast A.M. Bcr-Abl variants: biological and clinical aspects // Leuk. Res. - 2002. - 26. - P. 713-720.
11. Keeshan K., Mills K.I., Cotter T.G., McKenna S.L. Elevated Bcr-Abl expression levels are sufficient for a haematopoietic cell line to acquire a drug-resistant phenotype // Leukemia. - 2001. - 15. - P. 1823-1833.
12. Hochhaus A. Molecular response and resistance to Imatinib // Hematology J. - 2003. - 4. - P. 15-20.
13. Ottmann O.G., Druker B.J., Sawyers C.L., et al. A phase II study of imatinib in patients with relapsed and refractory Philadelphia chromosome-positive acute lymphoid leukemia // Blood. - 2002. - 100. - P. 1965-1971.
14. Yamaguchi H., Inokuchi K., Yokommizo E. et al. Philadelphia chromosome-positive acute myeloid leukemia with tetraploidy // Int. J. Hematol. - 2003. - 75. - P. 63-66.
15. Viniou N.A., Vassilakopoulos T.P., Giakoumi X. et al. Ida-FLAG plus imatinib mesylate-induced molecular remission in a patient with chemoresistant Ph1 + acute myeloid leukemia // Eur. J. Haematol. - 2004. - 72. - P. 58-60.